Anti-C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single-centre, cross-sectional study

Br J Dermatol. 2021 Sep;185(3):657-658. doi: 10.1111/bjd.20412. Epub 2021 Jun 11.

Authors

D J Dijkstra¹, S I E Liem², N M van Leeuwen², C M Fehres², J K de Vries-Bouwstra², L A Trouw¹

Affiliations

¹ Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.

No abstract available

Publication types

Letter

MeSH terms

Autoantibodies
Biomarkers
Complement C1q
Cross-Sectional Studies
Humans
Lung
Lupus Erythematosus, Systemic*
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / diagnosis

Substances

Autoantibodies
Biomarkers
Complement C1q